This is a protocol for a Cochrane Review (intervention). The objectives are as follows:
To determine the efficacy of LPD (0.6 to 0.8 g/kg/day) in preventing the progression of CKD towards kidney failure and in reducing the incidence of kidney failure and death (any cause) in adult patients with DKD. Moreover, the effect of LPD on adverse events ( e.g. malnutrition, hyperglycaemic events, or quality of life) and compliance was also evaluated.
This is a protocol.